Minerva Neurosciences Inc.
NERV | NASDAQ
$3.77
+$0.09 (+2.45%)
Sep 22, 2026, 12:18 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 24.65B | 32.76M | 82.3M | 12.29M | 15.25M | 17.29M | 21.36M | 26.53M | 30.98M | 34.92M | 40.91M | 46.9M | 51.8M | 35.98M | 36.09M | 40.22M | 49.75M | 54.95M | 60.76M | 65.59M | 74.21M | 80.14M |
Short-Term Investments | 50.62B | 45.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 487.03M | 50.98K | n/a | 201.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -51.08K | -51.08K | -1 | n/a | 14.81K | 14.81K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.47B | 941.88K | 797.68K | 733.53K | 299.62K | 634.8K | 906.9K | 1.41M | 428.02K | 702.55K | 1.09M | 1.32M | 429.15K | 696.05K | 4.07M | 3.22M | 100K | 100K | 100K | 100K | 100K | 100K |
Total Current Assets | 79.73B | 79.11M | 83.1M | 13.02M | 15.55M | 17.92M | 22.27M | 27.94M | 31.41M | 35.62M | 42M | 48.23M | 52.23M | 36.67M | 40.16M | 44.84M | 50.04M | 55.7M | 62.2M | 67.44M | 75.23M | 81.69M |
Property-Plant & Equipment | n/a | n/a | n/a | 1.36K | 2.72K | 4.08K | 5.44K | 6.8K | 8.16K | 9.52K | 10.88K | 12.25K | 13.61K | 14.97K | 16.33K | n/a | 51.08K | 51.08K | 51.08K | n/a | 14.94K | 58.95K |
Goodwill & Intangibles | 14.87B | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M | 14.88M | 14.89M | 14.89M | 14.9M | 14.91M | 14.91M | 14.92M | 14.92M | 14.92M | 14.87M | 30.12M | 30.07M | 30.07M |
Total Long-Term Assets | 15.36B | 14.92M | 14.87M | 15.07M | 14.87M | 14.87M | 14.87M | 14.88M | 14.88M | 14.89M | 14.9M | 14.91M | 14.91M | 14.92M | 14.93M | 14.92M | 14.92M | 14.92M | 14.92M | 30.12M | 30.1M | 30.14M |
Total Assets | 95.09B | 94.03M | 97.97M | 28.09M | 30.42M | 32.8M | 37.14M | 42.81M | 46.29M | 50.51M | 56.9M | 63.13M | 67.14M | 51.59M | 55.09M | 59.76M | 64.96M | 70.62M | 77.12M | 97.56M | 105.32M | 111.83M |
Account Payables | 1.45B | 2.12M | 639.71K | 944.49K | 896.8K | 639.95K | 1.61M | 553.19K | 828.35K | 1.44M | 1.81M | 1.4M | 298.25K | 961K | 969.67K | 532.89K | 1.52M | 1.59M | 1.85M | 1.2M | 1.59M | 1.13M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 3.96B | 1.97M | n/a | 1.21M | 878.79K | 439.4K | 363.18K | 1.16M | 2.4M | 652.34K | 590.77K | 1.17M | 889.96K | 449.28K | 14.83K | 1.14M | 1.06M | 1.23M | n/a | 1.2M | 1.98M | 1.68M |
Total Current Liabilities | 3.96B | 4.48M | 2.29M | 2.67M | 2.53M | 1.95M | 2.84M | 4.48M | 4.2M | 2.83M | 3.34M | 3.35M | 1.91M | 2.5M | 1.38M | 2.2M | 3.41M | 3.25M | 2.82M | 3.08M | 4.44M | 3.36M |
Long-Term Debt | n/a | 64.96M | n/a | n/a | n/a | n/a | n/a | n/a | 86.58M | 84.27M | n/a | n/a | n/a | n/a | n/a | n/a | 69.93M | 68.11M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 292.69B | 278.6M | 236.43M | 60M | 60M | 60M | 60M | 60M | n/a | n/a | 82.02M | 79.83M | 77.74M | 75.71M | 73.73M | 71.81M | n/a | n/a | 66.33M | 64.59M | 62.91M | 61.3M |
Total Long-Term Liabilities | 292.69B | 343.56M | 236.43M | 60M | 60M | 60M | 60M | 60M | 86.58M | 84.27M | 82.02M | 79.83M | 77.74M | 75.71M | 73.73M | 71.81M | 69.93M | 68.11M | 66.33M | 66.4M | 64.71M | 63.1M |
Total Liabilities | 296.65B | 348.04M | 238.72M | 62.67M | 62.53M | 61.95M | 62.84M | 64.48M | 90.78M | 87.1M | 85.36M | 83.18M | 79.65M | 78.21M | 75.11M | 74M | 73.34M | 71.35M | 69.15M | 69.48M | 69.16M | 66.46M |
Total Debt | n/a | 64.96M | n/a | n/a | n/a | n/a | n/a | n/a | 86.58M | 84.27M | n/a | n/a | n/a | n/a | n/a | n/a | 69.93M | 68.11M | n/a | n/a | 16.29K | 64.35K |
Book Value | -201.56B | -254.01M | -140.75M | -34.58M | -32.11M | -29.15M | -25.69M | -21.67M | -44.49M | -36.59M | -28.46M | -20.05M | -12.51M | -26.62M | -20.02M | -14.25M | -8.38M | -736.13K | 7.98M | 28.08M | 36.17M | 45.37M |
Book Value Per Share | -2.55K | -5.79 | -12.66 | -4.57 | -4.24 | -3.85 | -3.39 | -2.86 | -5.88 | -4.83 | -3.76 | -2.65 | -2.27 | -4.98 | -3.75 | -2.67 | -1.57 | -0.14 | 1.49 | 5.26 | 6.77 | 8.50 |
Common Stock | 4.72M | 4.38K | 4.33K | 699 | 699 | 699 | 699 | 699 | 699 | 699 | 699 | 699 | 699 | 534 | 534 | 534 | 534 | 4.27K | 534 | 4.27K | 4.27K | 4.27K |
Retained Earnings | -796.74B | -814.2M | -688.8M | -405.13M | -402.39M | -399.13M | -395.38M | -391.1M | -413.62M | -405.38M | -396.82M | -387.79M | -379.97M | -373.78M | -366.81M | -360.08M | -353.18M | -344.47M | -334.7M | -313.39M | -304.19M | -293.6M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -201.56B | -254.01M | -140.75M | -34.58M | -32.11M | -29.15M | -25.69M | -21.67M | -44.49M | -36.59M | -28.46M | -20.05M | -12.51M | -26.62M | -20.02M | -14.25M | -8.38M | -736.13K | 7.98M | 28.08M | 36.17M | 45.37M |
Total Investments | 50.62B | 45.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NERV